On the other hand, chromosomal rearrangements between TMPRSS2 and ERG (TMPRSS2:ERG), made by AR binding to the “breakpoint ARE” in this region, occur in around 50% of prostate cancers [90,91,92,93]. The gene discussed is TMPRSS2; the disease is prostate carcinoma.